if that is the modality they choose. (5) Patient quality of life metric Section 1115A(b)(2)(B) of the Social Security Act ( 42 U.S.C. 1315a(b)(2)(B) ) is amended by adding at the end the following new subparagraph: (i) A patient quality of life metric for all patients utilizing dialysis regardless of modality with the intent of measuring and improving patient quality of life on dialysis. . 5. Ensuring medicare beneficiaries have access to in-home labs (a) In general The Secretary shall establish reimbursements for an add-on payment to cover travel costs and mailing costs associated with specimen collection of at-home clinical laboratory tests for eligible Medicare beneficiaries. (b) Coverage The add-on payment shall apply to all at-home clinical laboratory tests currently reimbursed under Part B as ordered by an eligible Medicare provider. (c) Eligible beneficiaries The Secretary shall determine the screening tool or utilization management that would trigger beneficiary eligibility for at-home clinical laboratory tests. Eligibility shall be more comprehensive than the homebound status as defined in sections 1835(a) and 1814(a) of the Social Security Act. The screening tool shall consider other criteria such as chronic conditions, social needs, barriers to accessing care, income level, or dual eligible status. (d) Eligible suppliers The Secretary shall determine eligible suppliers for specimen collection of at-home clinical lab tests. (e) Payment for travel allowance The Secretary shall establish payment methodology for the travel allowance reimbursement. The methodology shall account for geographic variation in costs of transportation. (f) Payment for mailing costs The Secretary shall establish payment methodology for reimbursement of the cost for mailing completed at-home clinical lab tests. The reimbursement structure shall be tiered on shipping based upon the nature of the collection and processing needs, for example cold chain requirements, time sensitively, and other infectious disease protocols. (g)